Genome Sequencing Market - Global Outlook and Forecast 2021-2026
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Genome Sequencing Market Report
The global genome sequencing market by revenue is expected to grow at a CAGR of over 9% during the period 2021–2026.
The global market is expected to grow due to the growing number of rare, terminal, and complex diseases, especially cancer. The constant increase in cancer cases is proportionately increasing the number of sequencing-based diagnostics and treatment options in the market. The introduction of single-cell sequencing technology performs advanced sequencing, thereby helping in cell mapping of tumor cells. This technology is widely used in several tumor researches and has been significantly beneficial for developing new diagnostic and anti-tumor treatment methods. The single-cell analysis has become a standard application both in basic and translational research. This technology is widely used in the field of reproductive and embryonic medicine. It can sequence and quantify the whole genome of germ cells and embryonic cells at the single-cell level, thereby helping researchers to understand the occurrence of germ cells.
The following factors are likely to contribute to the growth of the genome sequencing market during the forecast period:
Global Genome Sequencing Market Segmentation
The global genome sequencing market research report includes a detailed segmentation by product, application, end-user, geography. The steady rise in the sale of high-end consumables in commercial laboratories, research institutes, academic institutes, and large pharma and biotech companies performing a high volume of sequencing-based processes is a significant factor responsible for the growth of consumables. In 2020, the consumables segment accounted for the largest share in the market with 81%. The recurring application of consumables to perform a wide range of sequencing-based studies and diagnostics is another critical factor for high sales for consumables. Moreover, increased preference for array-based genotyping consumables for a wide range of analysis, disease-related mutations, and genetic characteristics associated with cancer research is further expected to increase the demand for consumables during the forecast period. High innovations and the introduction of high throughput advanced technologies are likely to drive the application of sequencing devices. These devices are capable of sequencing million to billion reads in a single run in less time.
New cancer cases are expected to reach 24 million by 2030, which is likely to augur well for oncology genome sequencing growth. As cancer prevalence is growing, the need for effective patient stratification is driving research efforts to identify biomarkers and develop companion diagnostics. Genome sequencing has opened new ways of studying cancer-related conditions. Cancer sequencing using next-generation sequencing (NGS) methods provides more information in less time compared to traditional single-gene and array-based approaches. Hence, NGS technology has the potential to change the future of oncology and deliver personalized medicine. They have revolutionized the diagnosis and treatment of acute myeloid leukemia (AML) with accurate testing, classification, and the ability to take advantage of precision medicine.
The presence of several research institutes and stand-alone genomic laboratories in the US, the UK, Germany, France, and China is a major factor responsible for the growth of genome sequencing devices. To develop personalized and effective new therapies that restore mobility, enhance the quality of life, and improve surgical outcomes for patients with multiple disorders, these centers perform extensive research on sequence structural levels of genomics. Hence, the increased focus on unraveling genetic components of common and complex diseases, including cancer diagnostics, neurological disorders, infectious diseases, and rare childhood disorders, influences the market.
Product
North America and Europe are the largest genome sequencing market across the globe. They are the leading countries to increase the usage of genome sequencing-based healthcare and diagnostics. The US is the largest revenue contributor to the North American market. The advanced healthcare infrastructure and the increased awareness have slowly increased genome sequencing and cell and gene therapies technology penetration. Multiple initiatives for human genome projects in the US have improved patients' flow seeking treatment for several terminal and genetic diseases. With advances in technology and the increased demand for personalized treatment, the US genomic sequencing market is poised for growth. The increased awareness among European patients drives the application of personal genome sequencing testing, especially for reproductive health. There is an increased number of consumer genomic service providers in the market.
Geography
Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, BGI, Pacific Biosciences, Oxford Nanopore Technology are the major vendors in the market. The market is competitive and is evolving with the introduction of new technologies in the market. Several companies are developing or commercializing products, expanding their manufacturing facilities, partnering with others in the market. For instance, in 2020, Illumina introduced software for whole-genome analysis to examine rare diseases. Similarly, Thermo Fischer scientific has made a strategic partnership with First genetics JCS to promote NGS in Russia. The Oxford Nanopore technology, nanopore-based sequencing, and Pacbio’s SMRT technology-based sequencing revolutionize genome sequencing by reducing cost and increasing throughput, attracting end-users to shift from conventional sanger methods to advanced methods in the market.
Prominent Vendors
1. What technological advances are the genome sequencing market observing?
2. What is the growth rate of the genome sequencing market during the forecast period?
3. How the outbreak of the COVID-19 pandemic affect the genome sequencing market?
4. Which regions are likely to hold the largest revenue share during the forecast period?
5. Which end-user segment accounted for the largest market share in 2021?
The global genome sequencing market by revenue is expected to grow at a CAGR of over 9% during the period 2021–2026.
The global market is expected to grow due to the growing number of rare, terminal, and complex diseases, especially cancer. The constant increase in cancer cases is proportionately increasing the number of sequencing-based diagnostics and treatment options in the market. The introduction of single-cell sequencing technology performs advanced sequencing, thereby helping in cell mapping of tumor cells. This technology is widely used in several tumor researches and has been significantly beneficial for developing new diagnostic and anti-tumor treatment methods. The single-cell analysis has become a standard application both in basic and translational research. This technology is widely used in the field of reproductive and embryonic medicine. It can sequence and quantify the whole genome of germ cells and embryonic cells at the single-cell level, thereby helping researchers to understand the occurrence of germ cells.
The following factors are likely to contribute to the growth of the genome sequencing market during the forecast period:
- Increase in Demand for Single Cell Sequencing
- Introduction of Portable Genome Sequencing Devices
- The emergence of Nanopore, Third Generation Genome Sequencing Platform
Global Genome Sequencing Market Segmentation
The global genome sequencing market research report includes a detailed segmentation by product, application, end-user, geography. The steady rise in the sale of high-end consumables in commercial laboratories, research institutes, academic institutes, and large pharma and biotech companies performing a high volume of sequencing-based processes is a significant factor responsible for the growth of consumables. In 2020, the consumables segment accounted for the largest share in the market with 81%. The recurring application of consumables to perform a wide range of sequencing-based studies and diagnostics is another critical factor for high sales for consumables. Moreover, increased preference for array-based genotyping consumables for a wide range of analysis, disease-related mutations, and genetic characteristics associated with cancer research is further expected to increase the demand for consumables during the forecast period. High innovations and the introduction of high throughput advanced technologies are likely to drive the application of sequencing devices. These devices are capable of sequencing million to billion reads in a single run in less time.
New cancer cases are expected to reach 24 million by 2030, which is likely to augur well for oncology genome sequencing growth. As cancer prevalence is growing, the need for effective patient stratification is driving research efforts to identify biomarkers and develop companion diagnostics. Genome sequencing has opened new ways of studying cancer-related conditions. Cancer sequencing using next-generation sequencing (NGS) methods provides more information in less time compared to traditional single-gene and array-based approaches. Hence, NGS technology has the potential to change the future of oncology and deliver personalized medicine. They have revolutionized the diagnosis and treatment of acute myeloid leukemia (AML) with accurate testing, classification, and the ability to take advantage of precision medicine.
The presence of several research institutes and stand-alone genomic laboratories in the US, the UK, Germany, France, and China is a major factor responsible for the growth of genome sequencing devices. To develop personalized and effective new therapies that restore mobility, enhance the quality of life, and improve surgical outcomes for patients with multiple disorders, these centers perform extensive research on sequence structural levels of genomics. Hence, the increased focus on unraveling genetic components of common and complex diseases, including cancer diagnostics, neurological disorders, infectious diseases, and rare childhood disorders, influences the market.
Product
- Consumables
- Sequencers & Software
- Oncology
- Reproductive Health
- Complex Disease Research
- Microbial Research
- Others
- Academic & Research Institutes
- Pharma & Biotech Companies
- Consumer Genomic Service Providers
- Government & Commercial Laboratories
- Others
North America and Europe are the largest genome sequencing market across the globe. They are the leading countries to increase the usage of genome sequencing-based healthcare and diagnostics. The US is the largest revenue contributor to the North American market. The advanced healthcare infrastructure and the increased awareness have slowly increased genome sequencing and cell and gene therapies technology penetration. Multiple initiatives for human genome projects in the US have improved patients' flow seeking treatment for several terminal and genetic diseases. With advances in technology and the increased demand for personalized treatment, the US genomic sequencing market is poised for growth. The increased awareness among European patients drives the application of personal genome sequencing testing, especially for reproductive health. There is an increased number of consumer genomic service providers in the market.
Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- Turkey
- South Africa
- UAE
Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, BGI, Pacific Biosciences, Oxford Nanopore Technology are the major vendors in the market. The market is competitive and is evolving with the introduction of new technologies in the market. Several companies are developing or commercializing products, expanding their manufacturing facilities, partnering with others in the market. For instance, in 2020, Illumina introduced software for whole-genome analysis to examine rare diseases. Similarly, Thermo Fischer scientific has made a strategic partnership with First genetics JCS to promote NGS in Russia. The Oxford Nanopore technology, nanopore-based sequencing, and Pacbio’s SMRT technology-based sequencing revolutionize genome sequencing by reducing cost and increasing throughput, attracting end-users to shift from conventional sanger methods to advanced methods in the market.
Prominent Vendors
- Illumina
- Thermo Fisher Scientific
- Oxford Nanopore Technology
- Pacific Biosciences
- F. Hoffmann-La Roche
- BGI
- PerkinElmer
- Siemens Healthineers
- Qiagen
- Macrogen
- Myriad
- Intrexon Bioinformatics
- Biomatters
- Cytiva
- 10x Genomics
- MGI Tech
- New England Biolabs
- DNASTAR
- Beckman Coulter
- VEROGEN
- Bio-Rad
1. What technological advances are the genome sequencing market observing?
2. What is the growth rate of the genome sequencing market during the forecast period?
3. How the outbreak of the COVID-19 pandemic affect the genome sequencing market?
4. Which regions are likely to hold the largest revenue share during the forecast period?
5. Which end-user segment accounted for the largest market share in 2021?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by End-user
4.4.4 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
8 MARKET OPPORTUNITIES & TRENDS
8.1 Increase In The Demand For Single-Cell Sequencing
8.2 Introduction Of Portable Genome Sequencing Devices
8.3 Emergence Of Nanopore, Third Generation Genome Sequencing Platform
9 MARKET GROWTH ENABLERS
9.1 Rising Patient Population
9.2 Declining Cost of Genome Sequencing
9.3 Increasing Genome Sequencing Service Providers
10 MARKET RESTRAINTS
10.1 Influence Of The COVID-19 Pandemic On The Genome Sequencing Market
10.2 Low Penetration Of Genome Sequencing In Developing Countries
10.3 Ethical & Regulatory Concerns Associated With Genome Sequencing
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 PRODUCT
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Consumables: Geography Segmentation
12.4 Sequencers & Software
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Sequencers & Software: Geography Segmentation
13 APPLICATION
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Oncology
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Oncology: Geography Segmentation
13.4 Reproductive Health
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Reproductive Health: Geography Segmentation
13.5 Complex Disease Research
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Complex Disease Research: Geography Segmentation
13.6 Microbial Research
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Microbial Research: Geography Segmentation
13.7 Others
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.7.3 Others: Geography Segmentation
14 END-USER
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Academic & Research Institutes
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Academic & Research Institute : Geography Segmentation
14.4 Pharma & Biotechnology Companies
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Pharma & Biotech Companies: Geography Segmentation
14.5 Consumer Genomic Service Providers
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Consumer Genomic Service Providers: Geography Segmentation
14.6 Government and Commercial Labs
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Government & Commercial Labs: Geography Segmentation
14.7 Others
14.7.1 Market Overview
14.7.2 Market Size & Forecast
14.7.3 Others: Geography Segmentation
15 GEOGRAPHY
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 NORTH AMERICA
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product
16.4 North America: Application
16.5 North America: End-User
16.6 Key Countries
16.6.1 US: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast
17 EUROPE
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product
17.4 Europe: Application
17.5 Europe: End-User
17.6 Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 France: Market Size & Forecast
17.6.3 UK: Market Size & Forecast
17.6.4 Italy: Market Size & Forecast
17.6.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 APAC: Product
18.4 APAC: Application
18.5 APAC: End-User
18.6 Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 Australia: Market Size & Forecast
18.6.4 South Korea: Market Size & Forecast
18.6.5 India: Market Size & Forecast
19 LATIN AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product
19.4 Latin America: Application
19.5 Latin America: End-User
19.6 Key Countries
19.6.1 Brazil: Market Size & Forecast
19.6.2 Mexico: Market Size & Forecast
19.6.3 Argentina: Market Size & Forecast
20 MIDDLE EAST AND AFRICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product
20.4 Middle East & Africa: Application
20.5 Middle East & Africa: End-User
20.6 Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 Saudi Arabia: Market Size & Forecast
20.6.3 UAE: Market Size & Forecast
20.6.4 South Africa: Market Size & Forecast
21 COMPETITIVE LANDSCAPE
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Illumina
21.2.2 Thermo Fisher Scientific
21.2.3 Oxford Nanopore Technology
21.2.4 Pacific Biosciences
21.2.5 F. Hoffmann-La Roche
21.2.6 BGI
22 KEY COMPANY PROFILES
22.1 Illumina
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Thermo Fisher Scientific
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Oxford NanoPore Technologies
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategy
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Pacific Biosciences
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 F.Hoffmann-La Roche
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 BGI
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities
23 OTHER PROMINENT VENDORS
23.1 PerkinElmer
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Siemens Healthineers
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Qiagen
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Macrogen
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 myriad Genetics
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Intrexon Bioinformatics
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Biomatter
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Cytiva
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 10x Genomics
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 MGI TECH
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 New England Biolabs
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 DNASTAR
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Beckman Coulter
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Verogen
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Bio-Rad
23.15.1 Business Overview
23.15.2 Product Offerings
24 REPORT SUMMARY
24.1 Key Takeaways
24.2 Strategic Recommendations
25 QUANTITATIVE SUMMARY
25.1 Market By Geography
25.2 Market By End-User
25.2.1 North America: End-User
25.2.2 Europe: End-User
25.2.3 APAC: End-User
25.2.4 Latin America: End-User
25.2.5 Middle East & Africa: End-User
25.3 Market By Application
25.3.1 North America: Application
25.3.2 Europe: Application
25.3.3 APAC: Application
25.3.4 Latin America: Application
25.3.5 Middle East & Africa: Application
25.4 Market By Product
25.4.1 North America: Product
25.4.2 Europe: Product
25.4.3 APAC: Product
25.4.4 Latin America: Product
25.4.5 Middle East & Africa: Product
26 APPENDIX
26.1 Abbreviations
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by End-user
4.4.4 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Overview
8 MARKET OPPORTUNITIES & TRENDS
8.1 Increase In The Demand For Single-Cell Sequencing
8.2 Introduction Of Portable Genome Sequencing Devices
8.3 Emergence Of Nanopore, Third Generation Genome Sequencing Platform
9 MARKET GROWTH ENABLERS
9.1 Rising Patient Population
9.2 Declining Cost of Genome Sequencing
9.3 Increasing Genome Sequencing Service Providers
10 MARKET RESTRAINTS
10.1 Influence Of The COVID-19 Pandemic On The Genome Sequencing Market
10.2 Low Penetration Of Genome Sequencing In Developing Countries
10.3 Ethical & Regulatory Concerns Associated With Genome Sequencing
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 PRODUCT
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Consumables: Geography Segmentation
12.4 Sequencers & Software
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Sequencers & Software: Geography Segmentation
13 APPLICATION
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Oncology
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Oncology: Geography Segmentation
13.4 Reproductive Health
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Reproductive Health: Geography Segmentation
13.5 Complex Disease Research
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Complex Disease Research: Geography Segmentation
13.6 Microbial Research
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Microbial Research: Geography Segmentation
13.7 Others
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.7.3 Others: Geography Segmentation
14 END-USER
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Academic & Research Institutes
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Academic & Research Institute : Geography Segmentation
14.4 Pharma & Biotechnology Companies
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Pharma & Biotech Companies: Geography Segmentation
14.5 Consumer Genomic Service Providers
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Consumer Genomic Service Providers: Geography Segmentation
14.6 Government and Commercial Labs
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Government & Commercial Labs: Geography Segmentation
14.7 Others
14.7.1 Market Overview
14.7.2 Market Size & Forecast
14.7.3 Others: Geography Segmentation
15 GEOGRAPHY
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 NORTH AMERICA
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product
16.4 North America: Application
16.5 North America: End-User
16.6 Key Countries
16.6.1 US: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast
17 EUROPE
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product
17.4 Europe: Application
17.5 Europe: End-User
17.6 Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 France: Market Size & Forecast
17.6.3 UK: Market Size & Forecast
17.6.4 Italy: Market Size & Forecast
17.6.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 APAC: Product
18.4 APAC: Application
18.5 APAC: End-User
18.6 Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 Australia: Market Size & Forecast
18.6.4 South Korea: Market Size & Forecast
18.6.5 India: Market Size & Forecast
19 LATIN AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product
19.4 Latin America: Application
19.5 Latin America: End-User
19.6 Key Countries
19.6.1 Brazil: Market Size & Forecast
19.6.2 Mexico: Market Size & Forecast
19.6.3 Argentina: Market Size & Forecast
20 MIDDLE EAST AND AFRICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product
20.4 Middle East & Africa: Application
20.5 Middle East & Africa: End-User
20.6 Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 Saudi Arabia: Market Size & Forecast
20.6.3 UAE: Market Size & Forecast
20.6.4 South Africa: Market Size & Forecast
21 COMPETITIVE LANDSCAPE
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Illumina
21.2.2 Thermo Fisher Scientific
21.2.3 Oxford Nanopore Technology
21.2.4 Pacific Biosciences
21.2.5 F. Hoffmann-La Roche
21.2.6 BGI
22 KEY COMPANY PROFILES
22.1 Illumina
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Thermo Fisher Scientific
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Oxford NanoPore Technologies
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategy
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Pacific Biosciences
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 F.Hoffmann-La Roche
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 BGI
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities
23 OTHER PROMINENT VENDORS
23.1 PerkinElmer
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Siemens Healthineers
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Qiagen
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Macrogen
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 myriad Genetics
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Intrexon Bioinformatics
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Biomatter
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Cytiva
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 10x Genomics
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 MGI TECH
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 New England Biolabs
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 DNASTAR
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Beckman Coulter
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Verogen
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Bio-Rad
23.15.1 Business Overview
23.15.2 Product Offerings
24 REPORT SUMMARY
24.1 Key Takeaways
24.2 Strategic Recommendations
25 QUANTITATIVE SUMMARY
25.1 Market By Geography
25.2 Market By End-User
25.2.1 North America: End-User
25.2.2 Europe: End-User
25.2.3 APAC: End-User
25.2.4 Latin America: End-User
25.2.5 Middle East & Africa: End-User
25.3 Market By Application
25.3.1 North America: Application
25.3.2 Europe: Application
25.3.3 APAC: Application
25.3.4 Latin America: Application
25.3.5 Middle East & Africa: Application
25.4 Market By Product
25.4.1 North America: Product
25.4.2 Europe: Product
25.4.3 APAC: Product
25.4.4 Latin America: Product
25.4.5 Middle East & Africa: Product
26 APPENDIX
26.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Genome Sequencing Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Benefits of Next Generation Sequencing
Exhibit 4 Impact of Increase in the Demand for Single Cell Sequencing
Exhibit 5 Advantages of Sigle Cell Sequencing
Exhibit 6 Impact of Introduction of Portable Genome Sequencing Devices
Exhibit 7 Impact of Emergence of Nanopore, Third Generation Genome Sequencing Platform
Exhibit 8 Impact of Rising Patient Population
Exhibit 9 Global Rare Diseases Statistics Overview
Exhibit 10 Prevalence Rate of Selected Rare Diseases Worldwide as of 2017 (per 100,000 population)
Exhibit 11 Impact of Declining Cost of Genome Sequencing
Exhibit 12 Lower Sequencing Cost Expands Customer and Application Reach
Exhibit 13 Impact of Increasing Genome Sequencing Service Providers
Exhibit 14 Impact of the Covid-19 Pandemic on the Genome Sequencing Market
Exhibit 15 COVID-19 Cases in Key Countries
Exhibit 16 Revenue Comparison of Illumina during COVID-19 Pandemic ($million)
Exhibit 17 Impact of Low Penetration of Genome Sequencing in Developing Countries
Exhibit 18 Impact Ethical & Regulatory Concerns Associated with Genome Sequencing
Exhibit 19 Global Genome Sequencing Market 2020–2026 ($ million)
Exhibit 20 Global Genome Sequencing Market by Product
Exhibit 21 Global Genome Sequencing Market by Application
Exhibit 22 Global Genome Sequencing Market by End-user
Exhibit 23 Global Genome Sequencing Market by Geography
Exhibit 24 Five Forces Analysis 2020
Exhibit 25 Incremental Growth by Product 2020 & 2026
Exhibit 26 Global Genome Sequencing Market by Product
Exhibit 27 Global Genome Sequencing Market by Product: Incremental Growth
Exhibit 28 Global Genome Sequencing Market by Product: Absolute Growth
Exhibit 29 Global Genome Sequencing Market by Consumables: Incremental Growth versus Absolute Growth
Exhibit 30 Global Genome Sequencing Market by Consumables 2020–2026 ($ million)
Exhibit 31 Incremental Growth by Geography 2020 & 2026
Exhibit 32 Global Genome Sequencing Market by Sequencers & Softwares: Incremental Growth versus Absolute Growth
Exhibit 33 Global Genome Sequencing Market by Sequencers & Software 2020–2026 ($ million)
Exhibit 34 Incremental Growth by Geography 2020 & 2026
Exhibit 35 Incremental Growth by Application 2020 & 2026
Exhibit 36 Global Genome Sequencing Market by Application
Exhibit 37 Global Genome Sequencing Market by Application: Incremental Growth
Exhibit 38 Global Genome Sequencing Market by Application: Absolute Growth
Exhibit 39 Global Genome Sequencing Market by Oncology: Incremental Growth versus Absolute Growth
Exhibit 40 Global Genome Sequencing Market by Oncology 2020–2026 ($ million)
Exhibit 41 Incremental Growth by Geography 2020 & 2026
Exhibit 42 Global Genome Sequencing Market by Reproductive Health: Incremental Growth versus Absolute Growth
Exhibit 43 Global Genome Sequencing Market by Reproductive Health 2020–2026 ($ million)
Exhibit 44 Incremental Growth by Geography 2020 & 2026
Exhibit 45 Global Genome Sequencing Market by Complex Disease Research: Incremental Growth versus Absolute Growth
Exhibit 46 Global Genome Sequencing Market by Complex Disease Research 2020–2026 ($ million)
Exhibit 47 Incremental Growth by Geography 2020 & 2026
Exhibit 48 Global Genome Sequencing Market by Microbial Research: Incremental Growth versus Absolute Growth
Exhibit 49 Global Genome Sequencing Market by Microbial Research 2020–2026 ($ million)
Exhibit 50 Incremental Growth by Geography 2020 & 2026
Exhibit 51 Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth
Exhibit 52 Global Genome Sequencing Market by Others 2020–2026 ($ million)
Exhibit 53 Incremental Growth by Geography 2020 & 2026
Exhibit 54 Incremental Growth by End-User 2020 & 2026
Exhibit 55 Global Genome Sequencing Market by End-User
Exhibit 56 Global Genome Sequencing Market by End-User: Incremental Growth
Exhibit 57 Global Genome Sequencing Market by End-User: Absolute Growth
Exhibit 58 Global Genome Sequencing Market by Academic & Research Institutes: Incremental Growth versus Absolute Growth
Exhibit 59 Global Genome Sequencing Market by Academic & Research Institutes 2020–2026 ($ million)
Exhibit 60 Incremental Growth by Geography 2020 & 2026
Exhibit 61 Global Genome Sequencing Market by Pharma & Biotech Companies: Incremental Growth versus Absolute Growth
Exhibit 62 Global Genome Sequencing Market by Pharma & Biotechnology Companies 2020–2026 ($ million)
Exhibit 63 Incremental Growth by Geography 2020 & 2026
Exhibit 64 Global Genome Sequencing Market by Consumer Genomic Service Provider: Incremental Growth versus Absolute Growth
Exhibit 65 Global Genome Sequencing Market by Consumer Genomic Service Providers 2020–2026 ($ million)
Exhibit 66 Incremental Growth by Geography 2020 & 2026
Exhibit 67 Global Genome Sequencing Market by Government & Commercial Labs: Incremental Growth versus Absolute Growth
Exhibit 68 Global Genome Sequencing Market by Government and Commercial Labs 2020–2026 ($ million)
Exhibit 69 Incremental Growth by Geography 2020 & 2026
Exhibit 70 Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth
Exhibit 71 Global Genome Sequencing Market by Others 2020–2026 ($ million)
Exhibit 72 Incremental Growth by Geography 2020 & 2026
Exhibit 73 Incremental Growth by Geography 2020 & 2026
Exhibit 74 Global Genome Sequencing Market by Geography
Exhibit 75 Global Genome Sequencing Market by Geography: Incremental Growth
Exhibit 76 Global Genome Sequencing Market by Geography: Absolute Growth
Exhibit 77 Genome Sequencing Market in North America: Key Countries in 2020
Exhibit 78 Genome Sequencing Market in North America: Incremental Growth versus Absolute Growth
Exhibit 79 Genome Sequencing Market in North America 2020–2026 ($ million)
Exhibit 80 Incremental Growth by Product 2020 & 2026
Exhibit 81 Incremental Growth by Application 2020 & 2026
Exhibit 82 Incremental Growth by End-User 2020 & 2026
Exhibit 83 Incremental Growth in North America 2020 & 2026
Exhibit 84 Genome Sequencing Market in US 2020–2026 ($ million)
Exhibit 85 Genome Sequencing Market in Canada 2020–2026 ($ million)
Exhibit 86 Genome Sequencing Market in Europe: Key Countries in 2020
Exhibit 87 Genome Sequencing Market in Europe: Incremental Growth versus Absolute Growth
Exhibit 88 Genome Sequencing Market in Europe 2020–2026 ($ million)
Exhibit 89 Incremental Growth by Product 2020 & 2026
Exhibit 90 Incremental Growth by Application 2020 & 2026
Exhibit 91 Incremental Growth by End-User 2020 & 2026
Exhibit 92 Incremental Growth in Europe 2020 & 2026
Exhibit 93 Genome Sequencing Market in Germany 2020–2026 ($ million)
Exhibit 94 Genome Sequencing Market in France 2020–2026 ($ million)
Exhibit 95 Genome Sequencing Market in UK 2020–2026 ($ million)
Exhibit 96 Genome Sequencing Market in Italy 2020–2026 ($ million)
Exhibit 97 Genome Sequencing Market in Spain 2020–2026 ($ million)
Exhibit 98 Genome Sequencing Market in APAC: Key Countries in 2020
Exhibit 99 Genome Sequencing Market in APAC: Incremental Growth versus Absolute Growth
Exhibit 100 Genome Sequencing Market in APAC 2020–2026 ($ million)
Exhibit 101 Incremental Growth by Product 2020 & 2026
Exhibit 102 Incremental Growth by Application 2020 & 2026
Exhibit 103 Incremental Growth by End-User 2020 & 2026
Exhibit 104 Incremental Growth in APAC 2020 & 2026
Exhibit 105 Genome Sequencing Market in China 2020–2026 ($ million)
Exhibit 106 Genome Sequencing Market in Japan 2020–2026 ($ million)
Exhibit 107 Genome Sequencing Market in Australia 2020–2026 ($ million)
Exhibit 108 Genome Sequencing Market in South Korea 2020–2026 ($ million)
Exhibit 109 Genome Sequencing Market in India 2020–2026 ($ million)
Exhibit 110 Genome Sequencing Market in Latin America: Key Countries in 2020
Exhibit 111 Global Genome Sequencing Market in Latin America: Incremental Growth versus Absolute Growth
Exhibit 112 Genome Sequencing Market in Latin America 2020–2026 ($ million)
Exhibit 113 Incremental Growth by Product 2020 & 2026
Exhibit 114 Incremental Growth by Application 2020 & 2026
Exhibit 115 Incremental Growth by End-User 2020 & 2026
Exhibit 116 Incremental Growth in Latin America 2020 & 2026
Exhibit 117 Genome Sequencing Market in Brazil 2020–2026 ($ million)
Exhibit 118 Genome Sequencing Market in Mexico 2020–2026 ($ million)
Exhibit 119 Genome Sequencing Market in Argentina 2020–2026 ($ million)
Exhibit 120 Genome Sequencing Market in Middle East & Africa: Key Countries in 2020
Exhibit 121 Genome Sequencing Market in Middle East & Africa: Incremental Growth versus Absolute Growth
Exhibit 122 Genome Sequencing Market in Middle East & Africa 2020–2026 ($ million)
Exhibit 123 Incremental Growth by Product 2020 & 2026
Exhibit 124 Incremental Growth by Application 2020 & 2026
Exhibit 125 Incremental Growth by End-User 2020 & 2026
Exhibit 126 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 127 Genome Sequencing Market in Turkey 2020–2026 ($ million)
Exhibit 128 Genome Sequencing Market in Saudi Arabia 2020–2026 ($ million)
Exhibit 129 Genome Sequencing Market in UAE 2020–2026 ($ million)
Exhibit 130 Genome Sequencing Market in South Africa 2020–2026 ($ million)
Exhibit 131 Vendor’s Market Shares in the Global Genome Sequencing Market-2020
Exhibit 132 Illumina Revenue 2017?2019 ($ millions)
Exhibit 133 Illumina Research & Development Expenditure 2017?2019 ($ millions)
Exhibit 134 Illumina Consumables & Sequencers Revenue 2017?2019 ($ millions)
Exhibit 135 Thermo Fisher Scientific Revenue 2017?2019 ($ millions)
Exhibit 136 Thermo Fisher Scientific Research & Development Expenditure 2017?2019 ($ millions)
Exhibit 137 Thermo Fisher Scientific: Revenue by Geography (%)
Exhibit 1 Segmentation of Global Genome Sequencing Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Benefits of Next Generation Sequencing
Exhibit 4 Impact of Increase in the Demand for Single Cell Sequencing
Exhibit 5 Advantages of Sigle Cell Sequencing
Exhibit 6 Impact of Introduction of Portable Genome Sequencing Devices
Exhibit 7 Impact of Emergence of Nanopore, Third Generation Genome Sequencing Platform
Exhibit 8 Impact of Rising Patient Population
Exhibit 9 Global Rare Diseases Statistics Overview
Exhibit 10 Prevalence Rate of Selected Rare Diseases Worldwide as of 2017 (per 100,000 population)
Exhibit 11 Impact of Declining Cost of Genome Sequencing
Exhibit 12 Lower Sequencing Cost Expands Customer and Application Reach
Exhibit 13 Impact of Increasing Genome Sequencing Service Providers
Exhibit 14 Impact of the Covid-19 Pandemic on the Genome Sequencing Market
Exhibit 15 COVID-19 Cases in Key Countries
Exhibit 16 Revenue Comparison of Illumina during COVID-19 Pandemic ($million)
Exhibit 17 Impact of Low Penetration of Genome Sequencing in Developing Countries
Exhibit 18 Impact Ethical & Regulatory Concerns Associated with Genome Sequencing
Exhibit 19 Global Genome Sequencing Market 2020–2026 ($ million)
Exhibit 20 Global Genome Sequencing Market by Product
Exhibit 21 Global Genome Sequencing Market by Application
Exhibit 22 Global Genome Sequencing Market by End-user
Exhibit 23 Global Genome Sequencing Market by Geography
Exhibit 24 Five Forces Analysis 2020
Exhibit 25 Incremental Growth by Product 2020 & 2026
Exhibit 26 Global Genome Sequencing Market by Product
Exhibit 27 Global Genome Sequencing Market by Product: Incremental Growth
Exhibit 28 Global Genome Sequencing Market by Product: Absolute Growth
Exhibit 29 Global Genome Sequencing Market by Consumables: Incremental Growth versus Absolute Growth
Exhibit 30 Global Genome Sequencing Market by Consumables 2020–2026 ($ million)
Exhibit 31 Incremental Growth by Geography 2020 & 2026
Exhibit 32 Global Genome Sequencing Market by Sequencers & Softwares: Incremental Growth versus Absolute Growth
Exhibit 33 Global Genome Sequencing Market by Sequencers & Software 2020–2026 ($ million)
Exhibit 34 Incremental Growth by Geography 2020 & 2026
Exhibit 35 Incremental Growth by Application 2020 & 2026
Exhibit 36 Global Genome Sequencing Market by Application
Exhibit 37 Global Genome Sequencing Market by Application: Incremental Growth
Exhibit 38 Global Genome Sequencing Market by Application: Absolute Growth
Exhibit 39 Global Genome Sequencing Market by Oncology: Incremental Growth versus Absolute Growth
Exhibit 40 Global Genome Sequencing Market by Oncology 2020–2026 ($ million)
Exhibit 41 Incremental Growth by Geography 2020 & 2026
Exhibit 42 Global Genome Sequencing Market by Reproductive Health: Incremental Growth versus Absolute Growth
Exhibit 43 Global Genome Sequencing Market by Reproductive Health 2020–2026 ($ million)
Exhibit 44 Incremental Growth by Geography 2020 & 2026
Exhibit 45 Global Genome Sequencing Market by Complex Disease Research: Incremental Growth versus Absolute Growth
Exhibit 46 Global Genome Sequencing Market by Complex Disease Research 2020–2026 ($ million)
Exhibit 47 Incremental Growth by Geography 2020 & 2026
Exhibit 48 Global Genome Sequencing Market by Microbial Research: Incremental Growth versus Absolute Growth
Exhibit 49 Global Genome Sequencing Market by Microbial Research 2020–2026 ($ million)
Exhibit 50 Incremental Growth by Geography 2020 & 2026
Exhibit 51 Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth
Exhibit 52 Global Genome Sequencing Market by Others 2020–2026 ($ million)
Exhibit 53 Incremental Growth by Geography 2020 & 2026
Exhibit 54 Incremental Growth by End-User 2020 & 2026
Exhibit 55 Global Genome Sequencing Market by End-User
Exhibit 56 Global Genome Sequencing Market by End-User: Incremental Growth
Exhibit 57 Global Genome Sequencing Market by End-User: Absolute Growth
Exhibit 58 Global Genome Sequencing Market by Academic & Research Institutes: Incremental Growth versus Absolute Growth
Exhibit 59 Global Genome Sequencing Market by Academic & Research Institutes 2020–2026 ($ million)
Exhibit 60 Incremental Growth by Geography 2020 & 2026
Exhibit 61 Global Genome Sequencing Market by Pharma & Biotech Companies: Incremental Growth versus Absolute Growth
Exhibit 62 Global Genome Sequencing Market by Pharma & Biotechnology Companies 2020–2026 ($ million)
Exhibit 63 Incremental Growth by Geography 2020 & 2026
Exhibit 64 Global Genome Sequencing Market by Consumer Genomic Service Provider: Incremental Growth versus Absolute Growth
Exhibit 65 Global Genome Sequencing Market by Consumer Genomic Service Providers 2020–2026 ($ million)
Exhibit 66 Incremental Growth by Geography 2020 & 2026
Exhibit 67 Global Genome Sequencing Market by Government & Commercial Labs: Incremental Growth versus Absolute Growth
Exhibit 68 Global Genome Sequencing Market by Government and Commercial Labs 2020–2026 ($ million)
Exhibit 69 Incremental Growth by Geography 2020 & 2026
Exhibit 70 Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth
Exhibit 71 Global Genome Sequencing Market by Others 2020–2026 ($ million)
Exhibit 72 Incremental Growth by Geography 2020 & 2026
Exhibit 73 Incremental Growth by Geography 2020 & 2026
Exhibit 74 Global Genome Sequencing Market by Geography
Exhibit 75 Global Genome Sequencing Market by Geography: Incremental Growth
Exhibit 76 Global Genome Sequencing Market by Geography: Absolute Growth
Exhibit 77 Genome Sequencing Market in North America: Key Countries in 2020
Exhibit 78 Genome Sequencing Market in North America: Incremental Growth versus Absolute Growth
Exhibit 79 Genome Sequencing Market in North America 2020–2026 ($ million)
Exhibit 80 Incremental Growth by Product 2020 & 2026
Exhibit 81 Incremental Growth by Application 2020 & 2026
Exhibit 82 Incremental Growth by End-User 2020 & 2026
Exhibit 83 Incremental Growth in North America 2020 & 2026
Exhibit 84 Genome Sequencing Market in US 2020–2026 ($ million)
Exhibit 85 Genome Sequencing Market in Canada 2020–2026 ($ million)
Exhibit 86 Genome Sequencing Market in Europe: Key Countries in 2020
Exhibit 87 Genome Sequencing Market in Europe: Incremental Growth versus Absolute Growth
Exhibit 88 Genome Sequencing Market in Europe 2020–2026 ($ million)
Exhibit 89 Incremental Growth by Product 2020 & 2026
Exhibit 90 Incremental Growth by Application 2020 & 2026
Exhibit 91 Incremental Growth by End-User 2020 & 2026
Exhibit 92 Incremental Growth in Europe 2020 & 2026
Exhibit 93 Genome Sequencing Market in Germany 2020–2026 ($ million)
Exhibit 94 Genome Sequencing Market in France 2020–2026 ($ million)
Exhibit 95 Genome Sequencing Market in UK 2020–2026 ($ million)
Exhibit 96 Genome Sequencing Market in Italy 2020–2026 ($ million)
Exhibit 97 Genome Sequencing Market in Spain 2020–2026 ($ million)
Exhibit 98 Genome Sequencing Market in APAC: Key Countries in 2020
Exhibit 99 Genome Sequencing Market in APAC: Incremental Growth versus Absolute Growth
Exhibit 100 Genome Sequencing Market in APAC 2020–2026 ($ million)
Exhibit 101 Incremental Growth by Product 2020 & 2026
Exhibit 102 Incremental Growth by Application 2020 & 2026
Exhibit 103 Incremental Growth by End-User 2020 & 2026
Exhibit 104 Incremental Growth in APAC 2020 & 2026
Exhibit 105 Genome Sequencing Market in China 2020–2026 ($ million)
Exhibit 106 Genome Sequencing Market in Japan 2020–2026 ($ million)
Exhibit 107 Genome Sequencing Market in Australia 2020–2026 ($ million)
Exhibit 108 Genome Sequencing Market in South Korea 2020–2026 ($ million)
Exhibit 109 Genome Sequencing Market in India 2020–2026 ($ million)
Exhibit 110 Genome Sequencing Market in Latin America: Key Countries in 2020
Exhibit 111 Global Genome Sequencing Market in Latin America: Incremental Growth versus Absolute Growth
Exhibit 112 Genome Sequencing Market in Latin America 2020–2026 ($ million)
Exhibit 113 Incremental Growth by Product 2020 & 2026
Exhibit 114 Incremental Growth by Application 2020 & 2026
Exhibit 115 Incremental Growth by End-User 2020 & 2026
Exhibit 116 Incremental Growth in Latin America 2020 & 2026
Exhibit 117 Genome Sequencing Market in Brazil 2020–2026 ($ million)
Exhibit 118 Genome Sequencing Market in Mexico 2020–2026 ($ million)
Exhibit 119 Genome Sequencing Market in Argentina 2020–2026 ($ million)
Exhibit 120 Genome Sequencing Market in Middle East & Africa: Key Countries in 2020
Exhibit 121 Genome Sequencing Market in Middle East & Africa: Incremental Growth versus Absolute Growth
Exhibit 122 Genome Sequencing Market in Middle East & Africa 2020–2026 ($ million)
Exhibit 123 Incremental Growth by Product 2020 & 2026
Exhibit 124 Incremental Growth by Application 2020 & 2026
Exhibit 125 Incremental Growth by End-User 2020 & 2026
Exhibit 126 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 127 Genome Sequencing Market in Turkey 2020–2026 ($ million)
Exhibit 128 Genome Sequencing Market in Saudi Arabia 2020–2026 ($ million)
Exhibit 129 Genome Sequencing Market in UAE 2020–2026 ($ million)
Exhibit 130 Genome Sequencing Market in South Africa 2020–2026 ($ million)
Exhibit 131 Vendor’s Market Shares in the Global Genome Sequencing Market-2020
Exhibit 132 Illumina Revenue 2017?2019 ($ millions)
Exhibit 133 Illumina Research & Development Expenditure 2017?2019 ($ millions)
Exhibit 134 Illumina Consumables & Sequencers Revenue 2017?2019 ($ millions)
Exhibit 135 Thermo Fisher Scientific Revenue 2017?2019 ($ millions)
Exhibit 136 Thermo Fisher Scientific Research & Development Expenditure 2017?2019 ($ millions)
Exhibit 137 Thermo Fisher Scientific: Revenue by Geography (%)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2020
Table 3 Comparison of Portable NGS Approaches to Existing Technologies
Table 4 Lower Sequencing Cost Broadens Customer and Application Reach
Table 5 Key Genome Sequencing Service Providers
Table 6 Various Generations of Sequencing Technologies
Table 7 Major Genome Sequencing Research Institutes
Table 8 Global Genome Sequencing Market: Vendors Ranking
Table 9 Illumina: Major Product Offerings
Table 10 Thermo Fisher Scientific: Major Product Offerings
Table 11 Oxford Nanopore Technologies: Major Product Offerings
Table 12 Pacific Biosciences: Major Product Offerings
Table 13 F. Hoffmann-La Roche: Major Product Offerings
Table 14 BGI: Major Product Offerings
Table 15 PerkinElmer: Major Product Offerings
Table 16 Siemens Healthineers: Major Product Offerings
Table 17 Qiagen: Major Product Offerings
Table 18 Macrogen: Major Product Offerings
Table 19 Myriad Genetics: Major Product Offerings
Table 20 Intrexon Bioinformatics: Major Product Offerings
Table 21 BioMatter: Major Product Offerings
Table 22 Cytiva: Major Product Offerings
Table 23 10x Genomics: Major Product Offerings
Table 24 MGI Tech: Major Product Offerings
Table 25 New England Biolabs: Major Product Offerings
Table 26 DNASTAR: Major Product Offerings
Table 27 Beckman Coulter: Major Product Offerings
Table 28 VEROGEN: Major Product Offerings
Table 29 Bio-Rad: Major Product Offerings
Table 30 Global Genome Sequencing Market by Geography 2020?2026 ($ million)
Table 31 Global Genome Sequencing Market by Geography 2020?2026 (%)
Table 32 Global Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 33 Global Genome Sequencing Market by End-User 2020?2026 (%)
Table 34 North America Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 35 North America Genome Sequencing Market by End-User 2020?2026 (%)
Table 36 Europe Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 37 Europe Genome Sequencing Market by End-User 2020?2026 (%)
Table 38 APAC Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 39 APAC Genome Sequencing Market by End-User 2020?2026 (%)
Table 40 Latin America Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 41 Latin America Genome Sequencing Market by End-User 2020?2026 (%)
Table 42 Middle East & Africa Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 43 Middle East & Africa Genome Sequencing Market by End-User 2020?2026 (%)
Table 44 Global Genome Sequencing Market by Application 2020?2026 ($ million)
Table 45 Global Genome Sequencing Market by Application 2020?2026 (%)
Table 46 North America Genome Sequencing Market by Application 2020?2026 ($ million)
Table 47 North America Genome Sequencing Market by Application 2020?2026 (%)
Table 48 Europe Genome Sequencing Market by Application 2020?2026 ($ million)
Table 49 Europe Genome Sequencing Market by Application 2020?2026 (%)
Table 50 APAC Genome Sequencing Market by Application 2020?2026 ($ million)
Table 51 APAC Genome Sequencing Market by Application 2020?2026 (%)
Table 52 Latin America Genome Sequencing Market by Application 2020?2026 ($ million)
Table 53 Latin America Genome Sequencing Market by Application 2020?2026 (%)
Table 54 Middle East & Africa Genome Sequencing Market by Application 2020?2026 ($ million)
Table 55 Middle East & Africa Genome Sequencing Market by Application 2020?2026 (%)
Table 56 Global Genome Sequencing Market by Product 2020?2026 ($ million)
Table 57 Global Genome Sequencing Market by Product 2020?2026 (%)
Table 58 North America Genome Sequencing Market by Product 2020?2026 ($ million)
Table 59 North America Genome Sequencing Market by Product 2020?2026 (%)
Table 60 Europe Genome Sequencing Market by Product 2020?2026 ($ million)
Table 61 Europe Genome Sequencing Market by Product 2020?2026 (%)
Table 62 APAC Genome Sequencing Market by Product 2020?2026 ($ million)
Table 63 APAC Genome Sequencing Market by Product 2020?2026 (%)
Table 64 Latin America Genome Sequencing Market by Product 2020?2026 ($ million)
Table 65 Latin America Genome Sequencing Market by Product 2020?2026 (%)
Table 66 Middle East & Africa Genome Sequencing Market by Product 2020?2026 ($ million)
Table 67 Middle East &Africa Genome Sequencing Market by Product 2020?2026 (%)
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2020
Table 3 Comparison of Portable NGS Approaches to Existing Technologies
Table 4 Lower Sequencing Cost Broadens Customer and Application Reach
Table 5 Key Genome Sequencing Service Providers
Table 6 Various Generations of Sequencing Technologies
Table 7 Major Genome Sequencing Research Institutes
Table 8 Global Genome Sequencing Market: Vendors Ranking
Table 9 Illumina: Major Product Offerings
Table 10 Thermo Fisher Scientific: Major Product Offerings
Table 11 Oxford Nanopore Technologies: Major Product Offerings
Table 12 Pacific Biosciences: Major Product Offerings
Table 13 F. Hoffmann-La Roche: Major Product Offerings
Table 14 BGI: Major Product Offerings
Table 15 PerkinElmer: Major Product Offerings
Table 16 Siemens Healthineers: Major Product Offerings
Table 17 Qiagen: Major Product Offerings
Table 18 Macrogen: Major Product Offerings
Table 19 Myriad Genetics: Major Product Offerings
Table 20 Intrexon Bioinformatics: Major Product Offerings
Table 21 BioMatter: Major Product Offerings
Table 22 Cytiva: Major Product Offerings
Table 23 10x Genomics: Major Product Offerings
Table 24 MGI Tech: Major Product Offerings
Table 25 New England Biolabs: Major Product Offerings
Table 26 DNASTAR: Major Product Offerings
Table 27 Beckman Coulter: Major Product Offerings
Table 28 VEROGEN: Major Product Offerings
Table 29 Bio-Rad: Major Product Offerings
Table 30 Global Genome Sequencing Market by Geography 2020?2026 ($ million)
Table 31 Global Genome Sequencing Market by Geography 2020?2026 (%)
Table 32 Global Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 33 Global Genome Sequencing Market by End-User 2020?2026 (%)
Table 34 North America Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 35 North America Genome Sequencing Market by End-User 2020?2026 (%)
Table 36 Europe Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 37 Europe Genome Sequencing Market by End-User 2020?2026 (%)
Table 38 APAC Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 39 APAC Genome Sequencing Market by End-User 2020?2026 (%)
Table 40 Latin America Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 41 Latin America Genome Sequencing Market by End-User 2020?2026 (%)
Table 42 Middle East & Africa Genome Sequencing Market by End-User 2020?2026 ($ million)
Table 43 Middle East & Africa Genome Sequencing Market by End-User 2020?2026 (%)
Table 44 Global Genome Sequencing Market by Application 2020?2026 ($ million)
Table 45 Global Genome Sequencing Market by Application 2020?2026 (%)
Table 46 North America Genome Sequencing Market by Application 2020?2026 ($ million)
Table 47 North America Genome Sequencing Market by Application 2020?2026 (%)
Table 48 Europe Genome Sequencing Market by Application 2020?2026 ($ million)
Table 49 Europe Genome Sequencing Market by Application 2020?2026 (%)
Table 50 APAC Genome Sequencing Market by Application 2020?2026 ($ million)
Table 51 APAC Genome Sequencing Market by Application 2020?2026 (%)
Table 52 Latin America Genome Sequencing Market by Application 2020?2026 ($ million)
Table 53 Latin America Genome Sequencing Market by Application 2020?2026 (%)
Table 54 Middle East & Africa Genome Sequencing Market by Application 2020?2026 ($ million)
Table 55 Middle East & Africa Genome Sequencing Market by Application 2020?2026 (%)
Table 56 Global Genome Sequencing Market by Product 2020?2026 ($ million)
Table 57 Global Genome Sequencing Market by Product 2020?2026 (%)
Table 58 North America Genome Sequencing Market by Product 2020?2026 ($ million)
Table 59 North America Genome Sequencing Market by Product 2020?2026 (%)
Table 60 Europe Genome Sequencing Market by Product 2020?2026 ($ million)
Table 61 Europe Genome Sequencing Market by Product 2020?2026 (%)
Table 62 APAC Genome Sequencing Market by Product 2020?2026 ($ million)
Table 63 APAC Genome Sequencing Market by Product 2020?2026 (%)
Table 64 Latin America Genome Sequencing Market by Product 2020?2026 ($ million)
Table 65 Latin America Genome Sequencing Market by Product 2020?2026 (%)
Table 66 Middle East & Africa Genome Sequencing Market by Product 2020?2026 ($ million)
Table 67 Middle East &Africa Genome Sequencing Market by Product 2020?2026 (%)
